MUMBAI: Shares of Divi's Laboratories rose a little over 4% after the company announced 29.3% year-on-year rise in its consolidated net profit to Rs502.02 crore for the quarter ended March. At 12pm, ...
Motilal Oswal Financial Services raised the target price for Divi's Laboratories to Rs 3,900 after the company delivered a strong beat on earnings in 4QFY24, fueled by a revival in the Custom ...
Divi's Labs Q3 Results: Divi’s Laboratories declared its financial results for the quarter ending December 31, 2025 (Q3FY26), following the Board meeting held on February 11, 2026. For the nine months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results